Expert Insight

SELECT trial results: Wegovy’s benefits are real, but access remains an issue

SELECT trial results demonstrate Wegovy's effectiveness in reducing the risk of serious cardiovascular events by 20%. We explain why access challenges, including high costs and limited coverage, continue to pose obstacles to its widespread use and what you should keep an eye on in the upcoming months.

SPONSORED BY

INTENDED AUDIENCE
  • Employers
  • Hospitals and health systems

AFTER YOU READ THIS
  • You will learn about the known cardiovascular health benefits of weight loss and GLP-1 use and notable SELECT trial results.

  • You will understand why ongoing access barriers limit Wegovy's reach for patients.

  • You will know what developments to watch for to guide your cardiovascular strategic planning moving forward.

Don't miss out on the latest Advisory Board insights

Create your free account to access 2 resources each month, including the latest research and webinars.

Want access without creating an account?

   

You have 2 free members-only resources remaining this month remaining this month.

1 free members-only resources remaining this month

1 free members-only resources remaining this month

You've reached your limit of free monthly insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free monthly insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.